A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy

The purpose of this study is to evaluate the long-term safety, tolerability, and efficacy of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA) in participants with cystic fibrosis.

Study ID: 2607
NCT Number: NCT05444257
Principal Investigator: Zachary Holliday, MD
Department: Medicine-Pulmonary & Environ
Eligibility: Both men and women 12 years old to 100 years old. Does not accept healthy volunteers.

For questions about this study, please contact:

ClinicalTrialsInterest@health.missouri.edu
(573) 882-7026